Neoplasm by Cause — Trials

Neoplasm by Cause — Trials · CancerIndex

Clinical trials

Registered studies

708 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 101–135 of 135 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06834373	Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy	recruiting	Phase 2	41	Mayo ClinicOTHER	1	Jan 28, 2026	clinicaltrials
NCT05262010	A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years	recruiting	Phase 3	13,500	National Vaccine and Serum Institute, ChinaINDUSTRY	1	Jan 16, 2026